Here we show that the ISGs PSMB9, ISG15, ISG20, OAS2 and MX1 and the DDX58 sensor which promotes IFN expression are associated with shorter overall survival time in canine DLBCL, regardless of the immunotherapeutic regimen used. This evidence concerns the gene ISG20 and diffuse large B-cell lymphoma.